|
Description:
|
|
Contributor: Taylor Lynch MD Educational Pearls: -
Anticholinergics are found in many medications, including over-the-counter remedies -
Medications include: -
Diphenhydramine -
Tricyclic antidepressants like amitriptyline -
Atropine -
Antipsychotics like olanzapine -
Antispasmodics - dicyclomine -
Jimsonweed -
Muscaria mushrooms -
Mechanism of action involves competitive antagonism of the muscarinic receptor -
Symptomatic presentation is easily remembered via the mnemonic: -
Dry as a bone - anhidrosis due to cholinergic antagonism at sweat glands -
Red as a beet - cutaneous vasodilation leads to skin flushing -
Hot as a hare - anhidrotic hyperthermia -
Blind as a bat - pupillary dilation and ineffective accommodation -
Mad as a hatter - anxiety, agitation, dysarthria, hallucinations, and others -
Clinical management -
ABCs -
Benzodiazepines for supportive care, agitation, and seizures -
Sodium bicarbonate for TCA toxicity due to widened QRS -
Activated charcoal if patient present -
Temperature monitoring -
Contact poison control with questions -
Physostigmine controversy -
Acetylcholinesterase inhibitor -
Black box warning for asystole and seizure -
Contraindicated in TCA overdoses -
Crosses blood-brain barrier, so useful for TCA overdoses -
Indicated only in certain anticholinergic overdose with delirium -
Disposition -
Admission criteria include: symptoms >6 hours, CNS findings, QRS prolongation, hyperthermia, and rhabdomyolysis -
ICU admission criteria include: delirium, dysrhythmias, seizures, coma, or requirement for physostigmine drip References 1. Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review. Clin Toxicol (Phila). 2018;56(2):101-107. doi:10.1080/15563650.2017.1342828 2. Nguyen TT, Armengol C, Wilhoite G, Cumpston KL, Wills BK. Adverse events from physostigmine: An observational study. Am J Emerg Med. 2018;36(1):141-142. doi:10.1016/j.ajem.2017.07.006 3. Scharman E, Erdman A, Wax P, et al. Diphenhydramine and dimenhydrinate poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2006;44(3):205-223. doi:10.1080/15563650600585920 4. Shervette RE 3rd, Schydlower M, Lampe RM, Fearnow RG. Jimson "loco" weed abuse in adolescents. Pediatrics. 1979;63(4):520-523. 5. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45(3):203-233. doi:10.1080/15563650701226192 Summarized by Jorge Chalit, OMSIII | Edited by Jorge Chalit |